USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
Report Highlights
The USA lateral flow immunoassay (LFIA) based rapid test market grew from $1,793.2 million in 2016 to $3,714.8 million in 2021 at a compound annual growth rate (CAGR) of 15.7%. The USA lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $3,714.8 million in 2021 to $2,346 million in 2026 at a compound annual growth rate (CAGR) of -8.8%.
USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the USA Lateral Flow Immunoassay (LFIA) Based Rapid Test market.
Reasons to Purchase
- Fully updated for 2022.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 from the Business Research Company covers market characteristics, size and growth, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the Lateral Flow Immunoassay (LFIA) Based Rapid Test market revenues, covering both the historic growth of the market and forecasting the future.
- The trends and strategies section highlights the likely future developments in the Lateral Flow Immunoassay (LFIA) Based Rapid Test market and suggests approaches.
Scope
Markets Covered: Lateral Flow Immunoassay (LFIA) Based Rapid Test
Geographic scope: USA
Time series: Five years historic and forecast
Data: Market value in $ billions.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : USA GDP Per Capita, 2015-2020, $
- Table 2 : USA, Population By Age Group, 2015-2025, Thousands
- Table 3 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
- Table 4 : USA Healthcare Services Market Size, 2016-2026, $ Billion
- Table 5 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
- Table 6 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
- Table 7 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
- Table 8 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
- Table 9 : Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Data Sources
- Figure 1 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
- Figure 2 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
- Figure 3 : USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market grew from $1547.8 million in 2016 to $2,924.5 million in 2021 at a compound annual growth rate (CAGR) of 13.6%. The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $2924.5 million in 2021 to $1666.6 million in 2026 at a compound annual ...
North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The North America lateral flow immunoassay (LFIA) based rapid test market grew from $1,988.5 million in 2016 to $4,145.4 million in 2021 at a compound annual growth rate (CAGR) of 15.8%. The North America lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $4,145.4 million in 2021 to $2,656.3 million in 2026 at a compound annual ...
Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Eastern Europe lateral flow immunoassay (LFIA) based rapid test market grew from $248.1 million in 2016 to $492.3 million in 2021 at a compound annual growth rate (CAGR) of 14.7%. The Eastern Europe lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $492.3 million in 2021 to $301.9 million in 2026 at a compound annual ...
Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Western Europe lateral flow immunoassay (LFIA) based rapid test market grew from $1,240.4 million in 2016 to $2,500.6 million in 2021 at a compound annual growth rate (CAGR) of 15.1%. The Western Europe lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $2,500.6 million in 2021 to $1,592.7 million in 2026 at a compound annual ...
South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The South America lateral flow immunoassay (LFIA) based rapid test market grew from $222.7 million in 2016 to $397 million in 2021 at a compound annual growth rate (CAGR) of 12.3%. The South America lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $397.0 million in 2021 to $222.9 million in 2026 at a compound annual ...
Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Africa lateral flow immunoassay (LFIA) based rapid test market grew from $145.0 million in 2016 to $229.3 million in 2021 at a compound annual growth rate (CAGR) of 9.6%. The Africa lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $229.3 million in 2021 to $158.9 million in 2026 at a compound annual growth rate ...
Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Middle East lateral flow immunoassay (LFIA) based rapid test market grew from $213.5 million in 2016 to $361.7 million in 2021 at a compound annual growth rate (CAGR) of 11.1%. The Middle East lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $361.7 million in 2021 to $237.3 million in 2026 at a compound annual ...
China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The China lateral flow immunoassay (LFIA) based rapid test market grew from $672.6 million in 2016 to $1,259.8 million in 2021 at a compound annual growth rate (CAGR) of 13.4%. The China lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $1,259.8 million in 2021 to $707.6 million in 2026 at a compound annual growth rate ...
India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The India lateral flow immunoassay (LFIA) based rapid test market grew from $139 million in 2016 to $261.9 million in 2021 at a compound annual growth rate (CAGR) of 13.5%. The India lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $261.9 million in 2021 to $138.7 million in 2026 at a compound annual growth rate ...
Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Japan lateral flow immunoassay (LFIA) based rapid test market grew from $300.8 million in 2016 to $580 million in 2021 at a compound annual growth rate (CAGR) of 14.0%. The Japan lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $580 million in 2021 to $335.3 million in 2026 at a compound annual growth rate ...
Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Australia lateral flow immunoassay (LFIA) based rapid test market grew from $84.7 million in 2016 to $163.1 million in 2021 at a compound annual growth rate (CAGR) of 14.0%. The Australia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $163.1 million in 2021 to $96.4 million in 2026 at a compound annual growth rate ...
Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Indonesia lateral flow immunoassay (LFIA) based rapid test market grew from $53.5 million in 2016 to $96 million in 2021 at a compound annual growth rate (CAGR) of 12.4%. The Indonesia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $96 million in 2021 to $54.1 million in 2026 at a compound annual growth rate ...
South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The South Korea lateral flow immunoassay (LFIA) based rapid test market grew from $80.2 million in 2016 to $155.9 million in 2021 at a compound annual growth rate (CAGR) of 14.2%. The South Korea lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $155.9 million in 2021 to $93.3 million in 2026 at a compound annual ...
UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The UK lateral flow immunoassay (LFIA) based rapid test market grew from $140.4 million in 2016 to $289.1 million in 2021 at a compound annual growth rate (CAGR) of 15.5%. The UK lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $289.1 million in 2021 to $180 million in 2026 at a compound annual growth rate ...
Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Germany lateral flow immunoassay (LFIA) based rapid test market grew from $280.4 million in 2016 to $569.4 million in 2021 at a compound annual growth rate (CAGR) of 15.2%. The Germany lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $569.4 million in 2021 to $358.2 million in 2026 at a compound annual growth rate ...
France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The France lateral flow immunoassay (LFIA) based rapid test market grew from $179.4 million in 2016 to $340.6 million in 2021 at a compound annual growth rate (CAGR) of 13.7%. The France lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $340.6 million in 2021 to $210.5 million in 2026 at a compound annual growth rate ...
Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Russia lateral flow immunoassay (LFIA) based rapid test market grew from $93.2 million in 2016 to $181.9 million in 2021 at a compound annual growth rate (CAGR) of 14.3%. The Russia lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $181.9 million in 2021 to $106.3 million in 2026 at a compound annual growth rate ...
Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
The Brazil lateral flow immunoassay (LFIA) based rapid test market grew from $102.9 million in 2016 to $182.0 million in 2021 at a compound annual growth rate (CAGR) of 12.1%. The Brazil lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $182.0 million in 2021 to $105.6 million in 2026 at a compound annual growth rate ...